SBIR/STTR Research Award
Methods for Improving Pancreatic Islet Transplantation
Award amount
$100,170Program and phase
SBIR · Phase IAward year
2004Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Synthecon, Inc.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Q89PFQ65RQT3
- Solicitation number
- PHS2004-2
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): Transplantation of islets of Langerhans has long held promise as a cure for Type 1 diabetes mellitus. In the past, most islet transplants failed to achieve insulin independence. Recently, a new immunosuppressan
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- New Bioreactor-based approach to stem cell/progenitor expansion for cell therapie
- SBIR Phase I: Agonist-mimetic Aptamers: a New Method to Control Stem Cell Fate
- New bioreactor-based approach to stem cell/progenitor expansion for cell therapie
- Methods for Improving Pancreatic Islet Transplantation
- BIOREACTOR FOR STEM CELL TISSUE ENGINEERING
Research funding history
7 SBIR/STTR records share this UEI (1996–2010). Reported award amounts total $2,007,926. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, National Science Foundation, National Aeronautics and Space Administration